IDEAYA to Reveal Phase 3 Melanoma Trial Results Soon
South San Francisco, California | April 10, 2026 IDEAYA Biosciences has announced that it will disclose topline results from...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
South San Francisco, California | April 10, 2026 IDEAYA Biosciences has announced that it will disclose topline results from...
QUEENSBURY, NEW YORK | December 31, 2025 — Delcath Systems announced the peer-reviewed publication of prespecified subgroup analyses from...
